Thomas Senderovitz is an M.D. from University of Copenhagen. He has more than 30 yrs experience from healthcare, pharmaceutical industry, biotech, CRO and regulatory authorities / governmental administration.

Since 2021 Senior Vice President Data Science at Novo Nordisk leading app 1100 data scientists across various domains and functions incl. Clinical Data Operations & Insights, Biostatistics/Statistical Programming, AI/ML & Real World Evidence, Pharmacometrics, Data Orchestration, External Affairs and Strategic and Digital Development. He recently joined the Board of Directors of Instem.

Previously CEO of the Danish Medicines Agency, Chair of Heads of Medicines Agencies Management Group and member of EMA Management Board.  Member of executive management of PAREXEL, Grünenthal and VP Global Exploratory Development of UCB, VP Clinical R&D Ferring Pharmaceuticals a.o.